Heron Therapeutics (HRTX) Current Leases: 2019-2025
Historic Current Leases for Heron Therapeutics (HRTX) over the last 7 years, with Sep 2025 value amounting to $780,000.
- Heron Therapeutics' Current Leases fell 75.99% to $780,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $780,000, marking a year-over-year decrease of 75.99%. This contributed to the annual value of $3.0 million for FY2024, which is 1.24% down from last year.
- Per Heron Therapeutics' latest filing, its Current Leases stood at $780,000 for Q3 2025, which was down 49.32% from $1.5 million recorded in Q2 2025.
- Heron Therapeutics' Current Leases' 5-year high stood at $3.3 million during Q3 2021, with a 5-year trough of $780,000 in Q3 2025.
- Moreover, its 3-year median value for Current Leases was $3.0 million (2023), whereas its average is $2.6 million.
- In the last 5 years, Heron Therapeutics' Current Leases rose by 23.80% in 2024 and then slumped by 75.99% in 2025.
- Heron Therapeutics' Current Leases (Quarterly) stood at $2.4 million in 2021, then increased by 11.46% to $2.7 million in 2022, then rose by 14.14% to $3.1 million in 2023, then fell by 1.24% to $3.0 million in 2024, then plummeted by 75.99% to $780,000 in 2025.
- Its Current Leases stands at $780,000 for Q3 2025, versus $1.5 million for Q2 2025 and $2.3 million for Q1 2025.